Protein drugs feature significant advantages over small molecule therapeutics, including low toxicity, high specificity, and development speed. However, the quality control requirements are ...

CluMPS—Clusters Magnified by Phase Separation—is a fluorescent reporter strategy for detecting protein clusters. It promises to facilitate the visualization of protein clusters that are too small to ...

Waters Corporation today announced the launch of the BioResolve ™ Protein A Affinity Columns with MaxPeak ™ Premier Technology, providing precise titer measurements. This launch marks the first set of ...

With demand for high-quality protein ingredients accelerating, manufacturers are under pressure to boost yield, purity and sustainability. Filtration, separation, and purification technologies ...

Proteoforms, the diverse molecular variants of proteins, are key to understanding cellular functions, disease mechanisms, and biomarker discovery in proteomics.

MILFORD, Mass., May 28, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, providing precise ...